Development and optimization of the activated charcoal suspension composition based on a mixture design approach
In this study, a new drug product containing activated charcoal was designed and developed. The excipient levels in the pharmaceutical formulation were optimized using a mixture design approach. The adsorption power of the activated charcoal suspension was selected as the critical quali tyattributeinfluencingtheefficacyofmedicaltreatment. Significantprognosticmodels(p<0.05)wereobtainedto describeindetailtheinterrelationsbetweenexcipientlevels and the adsorption power of the formulation. Liquid flavourhadacriticalimpactontheadsorptionpowerofthe suspension. Formulations containing the largest amount of liquidflavourshowedthelowestadsorptionpower.Sorbitolwasnotadsorbedontoactivatedcharcoalsostronglyas liquidflavour.Aslightincreaseinthecontentofcarboxymethylcellulose sodium led to a marked decrease in adsorption power. The obtained mathematical models and response surface allowed selection of the optimal composition ofexcipientsinafinaldrugproduct.
Keywords: activated charcoal, adsorption power, phenazone, experimental design, Quality by Design concept TheQualitybyDesignconceptisanessentialpartofthemodernapproachtopharmaceutical quality. It involves designing and developing formulations and manufacturing processestoensurepredefineddrugproductquality(1).Duetothecurrenttrendofbeing QualitybyDesigncompliant,theuseofexperimentaldesignsinpharmaceuticalsciences is increasing (2, 3) . This strategy can shorten a drug development phase and reduce the overall experimental work and costs (4, 5) . Furthermore, the use of experimental design techniquesenablesbetterunderstandingoftheeffectofmaterialattributesandprocess factorsonthefinaldrugproductquality(5).
This paper focuses on the application of experimental design in the development and optimization of a new drug product containing activated charcoal. The composition of excipients in the formulation was optimized using a mixture design approach according to the ICH Q8 guidelines (6) . The adsorption power of the activated charcoal suspension was consideredasthecriticalqualityattributetobestudiedinordertoestablishtheoptimal excipient levels in a fi nal drug product. Mixture design was applied to investigate the effect of varying the ratios of excipients and their interactions on the adsorption power of the pharmaceutical dosage form. Due to the fact that the response variable (adsorption power) is a function of the properties of diff erent components present in the suspension, a mathematical model was constructed to be er understand and predict the output response with respect to input variables.
EXPERIMENTAL
All chemicals and solvents were of analytical reagent grade. Phenazone (99%) and carboxymethylcellulose sodium salt (high viscosity) were obtained from Sigma-Aldrich (USA). Activated charcoal was provided by Pharma Cosmetic (Poland). Sorbitol and HPLC--grade acetonitrile were purchased from POCh (Poland). Liquid fl avour (cola aromatic base dissolved in triacetin) was purchased from Hoff mann (Poland). Ultrapure water was obtained from a Milli-Q water purifi cation system from Millipore (USA).
Preparation of the activated charcoal suspension
In the fi rst stage of the study, the suspension included the following excipients: sorbitol (as a sweetener), liquid fl avour and purifi ed water.
The required amount of sorbitol (according to Table I ) was dissolved in purifi ed water. The obtained solution was mixed with the activated charcoal in a porcelain mortar and then liquid fl avour was added.
In the second stage, a carboxymethylcellulose sodium salt (CMC) was added as a suspending agent to the formulation (Table II) . Sorbitol was dissolved in purifi ed water. The obtained solution was heated in a beaker to a temperature of 35 °C and agitated, the required amount of the polymer was dispersed in sorbitol solution. Agitation was continued without heating to obtain the appropriate consistency of the formulation and then 0.01 g of liquid fl avour was added. The obtained polymer dispersion was poured onto the charcoal powder in a mortar and mixed throughly. In this way, two grams of activated charcoal was incorporated into 10 g of the prepared gel formulation.
Adsorption power of activated charcoal suspension
The un-adsorbed phenazone concentration in the fi ltrate was measured using the RP--HPLC method. Adsorption power was measured as follows: 1.8 g of activated charcoal suspension was weighed into a 100-mL ground-glass stoppered conical fl ask, then 25-mL of a freshly prepared phenazone solution (10 mg mL -1 ) was added. This was shaken thoroughly for 15 min at room temperature and fi ltered. One (1.0) mL of the fi ltrate was transferred into a 25-mL volumetric fl ask and made up to the mark with ultrapure water. The obtained phenazone solution (1.0 mL) was transferred into a 25-mL volumetric fl ask and diluted with ultrapure water to the mark, mixed and fi ltered through a 0.22-mm membrane fi lter prior to being injected into a chromatographic column. Each suspension sample was prepared in triplicate. The concentration of phenazone in the investigated fi ltrate was calculated using the calibration curve prepared at nine diff erent concentration levels (in the range of 2.54-20.36 mg L -1 ).
HPLC method
A reversed phase high performance liquid chromatography method for the determination of phenazone in fi ltrate was developed with the aid of a HPLC system (Shimadzu, Japan) equipped with two LC-20AD solvent delivery pumps, a DGU-20A degasser and a diode array detector (SPD-M20A). Chromatographic experiments were performed on a GraceSmart TM RP 18 column (150 mm × 4.6 mm, 5 mm, WITKO, USA), combined with a SecurityGuard TM precolumn Gemini C18 (length 4 mm, internal diameter 3 mm, Phenomenex, USA). The mobile phase consisted of acetonitrile and water in a volume ratio of 25:75. All chromatographic experiments were performed in the isocratic mode. The fl ow rate was set to 0.5 mL min -1 and the injection volume was 20 mL. Chromatograms were recorded at 242 nm and were analyzed by means of the LCSolution so ware.
Experimental design
Mixture design with three factors was used for the optimization of excipient levels in the activated charcoal suspension. Mixture design is a special type of response surface methodology. In these experiments, the factors are the ingredients of a mixture and, consequently, their levels are not independent (5). The adsorption power of activated charcoal suspension was selected as the response variable. In the mixture design approach, the response is a function of the proportions of excipients present in a drug product (5, 7). The advantage of this methodology is the reduction of the number of experiments needed to optimize the response while maintaining the representativeness. The STATISTICA ® 10.0 so ware (StatSo , Tulsa, OK, USA) was used to construct the experimental design as well as to analyze the data. Experimental designs for the developed pharmaceutical dosage form are given in Tables I and II . The proportion for each excipient is expressed as a fraction of the mixture for each treatment combination; the sum of excipient proportions is equal to 100 %. The design resulted in fourteen suspension mixtures.
RESULTS AND DISCUSSION
In the fi rst stage of the study, three suspension excipients: sorbitol, liquid fl avour and purifi ed water were considered to be input variables with adsorption power as the response. Liquid fl avour was used to improve the taste and smell of the suspension. Sorbitol was included in the formulation as a sweetener. Due to the cathartic action of sorbitol, the combination of activated charcoal and sorbitol counteracted the constipation produced by charcoal alone. As a result, the elimination of toxic substances from the body was much easier. The upper limits of the two were found to be 15 % for sorbitol and 5 % for liquid fl avour. The imposed restrictions for sorbitol content resulted from the dose recommended by the European Pharmacopoeia (8). Higher content of sorbitol in a dosage form may lead to gastric irritation and diuretic eff ect.
Fourteen diff erent pharmaceutical formulations were prepared according to the design matrix described in Table I . The adsorption power of each suspension was determined by HPLC. Analysis of variance was carried out. Model signifi cance, lack of fi t and determination coeffi cient, which indicate the model fi tness, were evaluated. The multiple regression analysis indicated that the polynomial model was signifi cant (p < 0.05) in predicting the adsorption power of the suspension (Table III) . It could explain almost 98 % of all variances in the data (R 2 = 0.9803) and an insignifi cant lack of fi t was obtained. Residual analysis was also carried out in order to verify the assumptions used in statistical analysis. Residuals are the diff erence between the observed and predicted values (calculated from the mathematical model). Normal distribution of the residual values was confi rmed using the normal probability plot and the Shapiro-Wilk test. where v is the predicted response (adsorption power), x is the fraction of sorbitol in the mixture, y is the fraction of liquid fl avour in the mixture, z is the fraction of purifi ed water in the mixture.
The results of this study can be also graphically represented in the so-called triangular graph. Response surface describes the functional relationship between the adsorption power and excipient levels. As can be seen in Fig. 1a , liquid fl avour has a critical impact on the adsorption power of the activated charcoal suspension. Formulations containing the largest amount of liquid fl avour showed the lowest adsorption power values.
All suspensions, prepared in accordance with the design matrix from Table I , were characterized by unsatisfactory consistency. Thus, in the next stage of the study, carboxymethylcellulose sodium salt was included as a suspending agent in the pharmaceutical formulation in order to achieve appropriate consistency. This polymer increased the viscosity of the formulation and thereby reduced the sedimentation rate of suspended charcoal particles. Upper limits of the two excipients in the suspension were determined to be 15 % sorbitol and 1 % carboxymethylcellulose sodium salt. These excipient levels in the pharmaceutical formulation were optimized by the mixture design approach based on adsorption power measurements. A total of fourteen experiments were performed accord- ing to the design matrix given in Table II and the average adsorption power values were used in data analysis. A polynomial model was generated for the response value using multi-linear regression analysis. Adequacy of the developed model and the statistical signifi cance of the regression coeffi cients were tested using the analysis of variance. The results indicated that the model was signifi cant (p < 0.05). It could explain almost 99 % of all variances in the data (R 2 = 0.9980) and insignifi cant lack of fi t was obtained (Table III) . Moreover, the assumption of normal distribution of the residuals was also confi rmed by the normal probability plot and the Shapiro-Wilk test. where v is the predicted response (adsorption power), x is the fraction of sorbitol in the mixture, y is the fraction of carboxymethylcellulose sodium salt in the mixture, z is the fraction of purifi ed water in the mixture.
Graphical interpretation of the eff ects of excipients on the drug product quality and thus searching for the optimal formulation is possible by means of the so-called mixture response surface contour plot. As can be seen from Fig. 1b , carboxymethylcellulose sodium salt infl uences the adsorption power. A slight increase in the content of this polymer leads to a marked decrease of adsorption capacity. However, the use of 0.5 % carboxymethylcellulose sodium salt gives a suspension with satisfactory consistency and adsorption power. Due to the adsorption of liquid fl avour onto activated charcoal, it was excluded from the formulation. Finally, sorbitol, in an amount of about 12 %, was used as a sweetener to improve the taste of the charcoal suspension.
According to the results of the present study, it can be stated that 0.5 % carboxymethylcellulose sodium salt and 12-14 % sorbitol might be used in the formulation in order to achieve the desirable adsorption power of the fi nal suspension.
The application of this experimental methodology allowed a be er understanding of the infl uence of formulation excipients on the critical physicochemical quality a ribute (adsorption power) of the activated charcoal suspension. In contrast to the traditional experiment-based and trial-and-error approach, the applied methodology enabled to minimize the number of experiments to be conducted, without a signifi cant loss of information. Prognostic mathematical models were generated to describe in detail the interrelations between excipients and the critical quality a ribute of the fi nal suspension.
CONCLUSIONS
In this study, a new drug product containing activated charcoal was designed and developed using the mixture design approach. It allowed the modeling and analysis of the adsorption problem and thus selection of the optimal qualitative and quantitative composition of excipients, which guarantees the effi cacy of medical treatment. The results indicated that the mixture design is a useful tool for the activated charcoal drug product design and development, in accordance with the Quality by Design strategy.
